LQLing Qin

Ling Qin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ling Qin has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Reshaping the Immunometabolic Microenvironment via an Inflammation-Responsive Magnesium Delivery System to Tackle Bone Diseases

    by Xu Li, Hongwei Shao, Shunxiang Xu, Weiyang Liu, Yuan Zhang, Shian Zhang, Lizhen Zheng, Wenxue Tong, Jiankun Xu, Ling Qin

  • Open Access

    Green Radiative Cooling and Antimicrobial Materials Based on Polylactic Acid Oligomer Hexagonal Microspheres

    by Ziheng Zhang, Jun Li, Linlin Ma, Shirui Liu, Shunxiang Xu, Jun Hu

    Thermal management relying on passive radiative cooling materials can result in remarkable energy savings and greenhouse gas emissions reductions compared with traditional air conditioner-based cooling. However, few of these materials are degradable; thus, their disposal may generate a new environmental problem. At the same time, the COVID-19 pandemic and other infectious diseases have raised requirements for hygienic and antimicrobial performance. In this work, we use a facile solvent evaporation method to prepare a novel hierarchically porous polylactic acid oligomer (PLAO) coating that exhibits a radiative cooling effect, broad-spectrum antimicrobial properties, and degradability (with a degradation rate of 99.5% after 28 days). The radiative cooling effect is attributed to the hexagonal microsphere geometry and nanotexture of the polylactic acid oligomer (PLAO) crystals, which enhance reflectivity in the solar spectrum through a multiple scattering effect and exhibit high emissivity in the mid-infrared atmospheric window. The hierarchically porous PLAO coating material achieves an apparent temperature reduction of 6.8 °C under solar-spectrum irradiation (AM 1.5). The material also shows broad-spectrum antimicrobial and antiviral properties against coronaviruses (including the COVID-19 virus), with a reduction rate of 99.99% after 20 min; Gram-positive and Gram-negative bacteria, with a reduction rate of 99.99% after 1 h; fungi, with a reduction rate of 98.4% after 1 h; and multidrug-resistant bacteria, against which it produces a 0.22 cm inhibition ring after 12 h.

  • Open Access

    Green Radiative Cooling and Antimicrobial Materials Based on Polylactic Acid Oligomer Hexagonal Microspheres

    by Ziheng Zhang, Jun Li, Linlin Ma, Shirui Liu, Shunxiang Xu, Jun Hu

    Thermal management by passive radiative cooling materials can save energy and reduce emission of green-house gas remarkably compared with traditional air-conditioner cooling. However, few of these materials are degradable, thus their disposal may lead to another environmental problem. Meanwhile, the COVID-19 pandemic and other infectious diseases have raised the requirement of hygienic and antimicrobial performance. This work reports a discovery that polylactic acid oligomer (PLAO) material possesses radiative cooling effect, wide-spectrum antimicrobial property and degradability, simultaneously. The radiative cooling effect is attribute to the hexagonal microsphere geometry and nanotexture of polylactic acid oligomer (PLAO) crystals, which enhance the reflectivity in the solar spectrum through multiple scattering effect and exhibit high emissivity in the mid-infrared atmospheric window. Hierarchically porous PLAO coating material realizes an apparent temperature reduction of 6.8 ℃ under irradiation of solar spectrum (AM 1.5). The material also shows wide-spectrum antimicrobial and anti-viral properties against coronaviruses (including COVID-19 virus), gram-positive bacteria, gram-negative bacteria, fungi and multidrug resistant bacteria.

  • Open Access

    Building a medical products regulatory authority in Hong Kong: Why medical devices must lead the 2025–2026 reform agenda

    by Delon Yu-Sheng Hsueh, Wenxue Tong, Qing Lu, Jiankun Xu, Patrick S.H. Yung, Ling Qin

    Hong Kong's Department of Health announced in June 2025 a timetable for establishing the Centre for Medical Products Regulation (CMPR) by end 2026, including a phased primary evaluation roadmap for drugs (2026–2030). The statutory framework for medical devices remains in the drafting stage with no confirmed timetable, a pharmaceutical-first asymmetry that is the central policy concern. The existing Medical Device Administrative Control System provides voluntary listing via leveraged foreign approval or a conformity assessment body (CAB) pathway, but neither constitutes sovereign statutory approval. CAB certificates lack legal enforceability and cross-jurisdictional recognition, rendering the pathway commercially inert for locally developed innovations. Medical devices characterised by shorter development cycles, smaller clinical trial requirements, and alignment with Hong Kong's translational research strengths in the Greater Bay Area represent the highest-return near-term regulatory priority, yet receive subordinate treatment within the current reform. Dedicated legislation, institutional transition of the CAB into a statutory framework, and a confirmed device-track timetable are the three prerequisite actions. A constitutional and technical framework for CMPR–NMPA harmonization, grounded in mutual recognition under the "one country, two systems" architecture and operationalized through aligned dossier requirements is proposed as a novel contribution.

  • Open Access

    Hydrogen reshapes the senescent microenvironment of callus to enhance the healing of anti-osteoporotic-drug-induced atypical femoral fracture

    by Yuanming An, Haozhi Zhang, Yuantao Zhang, Shi'AN Zhang, Lizhen Zheng, Hongwei Shao, Wanting Du, Liming Cheng, Wei Sun, Jinhui Ma, et al.


  • Open Access

    Macrophages: Redefining extracellular matrix architecture through phenotypic switches as therapeutic targets

    by Bingyang Dai, Lizhen Zheng, James Chung-Wai Cheung, Yufeng Long, Jun Liu, Chunyi Wen, Ling Qin, Cheng Dong


  • Open Access

    Magnesium Silicate Composite Patch With Neurovascular Regenerative Properties Promotes Diabetic Wound Healing in Mice

    by Shunxiang Xu, Hongwei Shao, Zheyu Jin, Jiankun Xu, Fanyan Deng, Yuantao Zhang, Liangbin Zhou, Samuel Ka‐Kin Ling, Congqin Ning, Wenxue Tong, et al.

    Given the confluence of dysregulated inflammation, vasculopathy, and neuropathy, diabetic wounds pose a significant clinical challenge. Commercially available wound dressings often lack sufficient bioactivity, failing to meet clinical demands. Herein, we developed a PCL‐PLLA‐MgSiO3 (PP‐MgSi) patch with promising therapeutic effects. The PP‐MgSi composite patch was manufactured via electrospinning and characterized by controllable degradation and local release of Mg2+ and SiO32−. The patch showed favorable in vitro biocompatibility and bioactivity, notably increased angiogenesis, myelination, and neurite outgrowth. In type 2 diabetic mice, the PP‐MgSi patch exhibited MgSi dose‐dependent effects on enhancing diabetic wound healing by modulating the expression of TNF‐α, iNOS, and CD206 to balance inflammation, while boosting CD31 and β3‐tubulin levels to promote neurovascularization. With the significant suppression of pro‐inflammatory‐related TNF and IL‐17 pathways, while activating the peripheral nerve‐associated axon guidance pathway, blood vessel‐associated HIF‐1α and VEGF pathways, the PP‐MgSi patch ultimately achieved accelerated healing compared to the control group. Ultimately, the PP‐MgSi patch exhibited an accelerated repair rate, with comparable neovascularization and superior peripheral nerve regeneration capacity compared to three representative commercially available products. This proof‐of‐concept work presents a promising bioactive PP‐MgSi patch for future clinical diabetic wound management, particularly in terms of its neurovascular network recovery properties.


  • Open Access

    Hydrogen activates ACOD1-itaconate pathway to ameliorate steroid-associated osteonecrosis

    by Yuanming An, Lizhen Zheng, Shi'An Zhang, Haozhi Zhang, Yuantao Zhang, Hongwei Shao, Wenxue Tong, Ziyi Chen, Hao Yao, Zhenkang Wen, et al.


  • Open Access

    Green‐Prepared Magnesium Silicate Sprays Enhance the Repair of Burn‐Skin Wound and Appendages Regeneration in Rats and Minipigs

    by Shunxiang Xu, Yuantao Zhang, Bingyang Dai, Jiancun Rao, Fanyan Deng, Shi'AN Zhang, Hongwei Shao, Xu Li, Zheyu Jin, Tongzhou Liang, et al.

    Bioceramics provide promising tactics for wound healing, yet the on‐shelf products are still unmet, especially for skin appendages regeneration. Herein, the inorganic magnesium silicate sprays (MSS) as mineral factors to overcome the existing challenges is proposed. Results indicate MSS can be synthesized by a green method without organic solvents, templates, calcination, and harmful by‐products. With amorphous phase, nanoscale, and high specific surface area, MSS reveal an improved pH‐responsive degradability and excellent bioactivity for cell proliferation and migration. In rats, MSS display a dose‐dependent effect on accelerating burn‐wound repair via regulating the expressions of iNOS and IL‐10 to attenuate inflammation, elevating the expressions of CD31 and α‐SMA to improve vascularization, and boosting collagen deposition without ectopic calcification. The released Mg and Si ions synergistically potentiate the expressions of Gap43, Tubb3, and K19, suggesting the regeneration of peripheral nerves and hair follicles. These superior features are further verified by comparisons with commercial products, Dermlin® and 45S5 bioglass®, in both rats and minipigs. Motivated by these findings, three MSS‐based formulations of band‐aid patch, adhesive hydrogel, and antibacterial sprays are devised for specific scenarios. Taken together, this proof‐of concept study provides a promising bioactive mineral for future clinical skin wound repair and functional appendages regeneration.